» Articles » PMID: 37712756

VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor Encephalitis

Abstract

Pediatric and adult autoimmune encephalitis (AE) are often associated with Abs to the NR1 subunit of the N-methyl-d-aspartate (NMDA) receptor (NMDAR). Very little is known regarding the cerebrospinal fluid humoral immune profile and Ab genetics associated with pediatric anti-NMDAR-AE. Using a combination of cellular, molecular, and immunogenetics tools, we collected cerebrospinal fluid from pediatric subjects and generated 1) flow cytometry data to calculate the frequency of B cell subtypes in the cerebrospinal fluid of pediatric subjects with anti-NMDAR-AE and controls, 2) a panel of recombinant human Abs from a pediatric case of anti-NMDAR-AE that was refractory to treatment, and 3) a detailed analysis of the Ab genes that bound the NR1 subunit of the NMDAR. Ag-experienced B cells including memory cells, plasmablasts, and Ab-secreting cells were expanded in the pediatric anti-NMDAR-AE cohort, but not in the controls. These Ag-experienced B cells in the cerebrospinal fluid of a pediatric case of NMDAR-AE that was refractory to treatment had expanded use of variable H chain family 2 (VH2) genes with high somatic hypermutation that all bound to the NR1 subunit of the NMDAR. A CDR3 motif was identified in this refractory case that likely drove early stage activation and expansion of naive B cells to Ab-secreting cells, facilitating autoimmunity associated with pediatric anti-NMDAR-AE through the production of Abs that bind NR1. These features of humoral immune responses in the cerebrospinal fluid of pediatric anti-NMDAR-AE patients may be relevant for clinical diagnosis and treatment.

References
1.
Joshi C, Sivaprakasam K, Christley S, Ireland S, Rivas J, Zhang W . CSF-Derived CD4 T-Cell Diversity Is Reduced in Patients With Alzheimer Clinical Syndrome. Neurol Neuroimmunol Neuroinflamm. 2021; 9(1). PMC: 8631792. DOI: 10.1212/NXI.0000000000001106. View

2.
Schramm C, Douek D . Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design. Front Immunol. 2018; 9:1876. PMC: 6102386. DOI: 10.3389/fimmu.2018.01876. View

3.
Al-Diwani A, Theorell J, Damato V, Bull J, McGlashan N, Green E . Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis. Brain. 2022; 145(8):2742-2754. PMC: 9486890. DOI: 10.1093/brain/awac088. View

4.
Scheibe F, Pruss H, Mengel A, Kohler S, Numann A, Kohnlein M . Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology. 2016; 88(4):366-370. DOI: 10.1212/WNL.0000000000003536. View

5.
Nguyen L, Wang C . Anti-NMDA Receptor Autoimmune Encephalitis: Diagnosis and Management Strategies. Int J Gen Med. 2023; 16:7-21. PMC: 9826635. DOI: 10.2147/IJGM.S397429. View